On Friday, Gossamer Bio Inc (NASDAQ: GOSS) was -7.10% drop from the session before settling in for the closing price of $3.1. A 52-week range for GOSS has been $0.76 – $3.87.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 40.29%. When this article was written, the company’s average yearly earnings per share was at -187.00%. With a float of $185.63 million, this company’s outstanding shares have now reached $231.31 million.
Gossamer Bio Inc (GOSS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Gossamer Bio Inc stocks. The insider ownership of Gossamer Bio Inc is 19.80%, while institutional ownership is 61.74%. The most recent insider transaction that took place on Aug 19 ’25, was worth 50,016. In this transaction Director of this company bought 26,050 shares at a rate of $1.92, taking the stock ownership to the 58,050 shares.
Gossamer Bio Inc (GOSS) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.15 earnings per share (EPS) during the time that was better than consensus figure (set at -0.17) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -187.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.52% during the next five years compared to 40.29% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
You can see what Gossamer Bio Inc (GOSS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.69, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.58 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
As of the previous 9 days, the stock’s Stochastic %D was 6.57%.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 53.41%, which indicates a significant increase from 2.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.29 in the past 14 days, which was higher than the 0.21 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.99, while its 200-day Moving Average is $2.03. Nevertheless, the first resistance level for the watch stands at $3.07 in the near term. At $3.26, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.37. If the price goes on to break the first support level at $2.77, it is likely to go to the next support level at $2.66. Should the price break the second support level, the third support level stands at $2.47.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
There are 231,456K outstanding shares of the company, which has a market capitalization of 666.59 million. As of now, sales total 114,700 K while income totals -56,530 K. Its latest quarter income was 13,290 K while its last quarter net income were -48,220 K.
